Vitrolife AB (publ) (STO:VITR)
Sweden · Delayed Price · Currency is SEK 95.00
-1.45 (-1.50%)
Sep 4, 2026, 5:29 PM CET
Vitrolife AB Market Cap
Vitrolife AB has a market cap or net worth of 13.06 billion as of September 4, 2026. Its market cap has decreased by -27.86% in one year.
Market Cap
13.06B
Enterprise Value
13.84B
Revenue
3.39B
Ranking
n/a
PE Ratio
n/a
Stock Price
95.00
ChartMarket Cap Chart
Since June 27, 2001, Vitrolife AB's market cap has increased from 510.85M to 13.06B, an increase of 2,456.82%. That is a compound annual growth rate of 13.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 13.06B | -29.60% |
| Dec 30, 2025 | 18.55B | -36.27% |
| Dec 30, 2024 | 29.11B | 10.43% |
| Dec 29, 2023 | 26.36B | 4.56% |
| Dec 30, 2022 | 25.21B | -66.75% |
| Dec 30, 2021 | 75.82B | 223.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 66.51B |
| Sectra AB | 56.03B |
| Elekta AB | 21.04B |
| Nolato AB | 14.30B |
| MedCap AB | 8.51B |
| Xvivo Perfusion AB | 8.32B |
| CellaVision AB | 3.88B |
| BICO Group AB | 1.57B |